nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—Melatonin—MTNR1B—polycystic ovary syndrome	0.0182	0.68	CrCbGaD
Zolmitriptan—Chest discomfort—Metformin—polycystic ovary syndrome	0.00702	0.0457	CcSEcCtD
Zolmitriptan—Neuropathy—Metformin—polycystic ovary syndrome	0.00584	0.0379	CcSEcCtD
Zolmitriptan—Ear pain—Metformin—polycystic ovary syndrome	0.00529	0.0344	CcSEcCtD
Zolmitriptan—Melatonin—CYP19A1—polycystic ovary syndrome	0.00495	0.185	CrCbGaD
Zolmitriptan—Migraine—Metformin—polycystic ovary syndrome	0.00444	0.0289	CcSEcCtD
Zolmitriptan—Dehydration—Metformin—polycystic ovary syndrome	0.0042	0.0273	CcSEcCtD
Zolmitriptan—Influenza—Metformin—polycystic ovary syndrome	0.0039	0.0254	CcSEcCtD
Zolmitriptan—Pancreatitis—Metformin—polycystic ovary syndrome	0.00382	0.0249	CcSEcCtD
Zolmitriptan—Angina pectoris—Metformin—polycystic ovary syndrome	0.0038	0.0247	CcSEcCtD
Zolmitriptan—Melatonin—CYP1A1—polycystic ovary syndrome	0.00364	0.136	CrCbGaD
Zolmitriptan—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00341	0.0222	CcSEcCtD
Zolmitriptan—Bradycardia—Metformin—polycystic ovary syndrome	0.00318	0.0207	CcSEcCtD
Zolmitriptan—Rhinitis—Metformin—polycystic ovary syndrome	0.00313	0.0203	CcSEcCtD
Zolmitriptan—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00311	0.0202	CcSEcCtD
Zolmitriptan—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00307	0.02	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00307	0.0199	CcSEcCtD
Zolmitriptan—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0029	0.0188	CcSEcCtD
Zolmitriptan—Angiopathy—Metformin—polycystic ovary syndrome	0.00283	0.0184	CcSEcCtD
Zolmitriptan—Immune system disorder—Metformin—polycystic ovary syndrome	0.00282	0.0183	CcSEcCtD
Zolmitriptan—Chills—Metformin—polycystic ovary syndrome	0.0028	0.0182	CcSEcCtD
Zolmitriptan—Erythema—Metformin—polycystic ovary syndrome	0.00272	0.0177	CcSEcCtD
Zolmitriptan—Dysgeusia—Metformin—polycystic ovary syndrome	0.00266	0.0173	CcSEcCtD
Zolmitriptan—Muscle spasms—Metformin—polycystic ovary syndrome	0.00261	0.017	CcSEcCtD
Zolmitriptan—Tremor—Metformin—polycystic ovary syndrome	0.00255	0.0165	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00252	0.0164	CcSEcCtD
Zolmitriptan—Malaise—Metformin—polycystic ovary syndrome	0.00245	0.0159	CcSEcCtD
Zolmitriptan—Syncope—Metformin—polycystic ovary syndrome	0.00244	0.0158	CcSEcCtD
Zolmitriptan—Palpitations—Metformin—polycystic ovary syndrome	0.0024	0.0156	CcSEcCtD
Zolmitriptan—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00239	0.0155	CcSEcCtD
Zolmitriptan—Hypertension—Metformin—polycystic ovary syndrome	0.00235	0.0153	CcSEcCtD
Zolmitriptan—Chest pain—Metformin—polycystic ovary syndrome	0.00231	0.015	CcSEcCtD
Zolmitriptan—Myalgia—Metformin—polycystic ovary syndrome	0.00231	0.015	CcSEcCtD
Zolmitriptan—Discomfort—Metformin—polycystic ovary syndrome	0.00229	0.0149	CcSEcCtD
Zolmitriptan—Oedema—Metformin—polycystic ovary syndrome	0.00222	0.0144	CcSEcCtD
Zolmitriptan—Infection—Metformin—polycystic ovary syndrome	0.0022	0.0143	CcSEcCtD
Zolmitriptan—Shock—Metformin—polycystic ovary syndrome	0.00218	0.0142	CcSEcCtD
Zolmitriptan—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00217	0.0141	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00217	0.0141	CcSEcCtD
Zolmitriptan—Skin disorder—Metformin—polycystic ovary syndrome	0.00215	0.014	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00214	0.0139	CcSEcCtD
Zolmitriptan—Anorexia—Metformin—polycystic ovary syndrome	0.00211	0.0137	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00202	0.0131	CcSEcCtD
Zolmitriptan—Paraesthesia—Metformin—polycystic ovary syndrome	0.00199	0.0129	CcSEcCtD
Zolmitriptan—Dyspnoea—Metformin—polycystic ovary syndrome	0.00198	0.0129	CcSEcCtD
Zolmitriptan—Somnolence—Metformin—polycystic ovary syndrome	0.00197	0.0128	CcSEcCtD
Zolmitriptan—Dyspepsia—Metformin—polycystic ovary syndrome	0.00195	0.0127	CcSEcCtD
Zolmitriptan—Decreased appetite—Metformin—polycystic ovary syndrome	0.00193	0.0125	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00191	0.0124	CcSEcCtD
Zolmitriptan—Constipation—Metformin—polycystic ovary syndrome	0.0019	0.0123	CcSEcCtD
Zolmitriptan—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00183	0.0119	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00181	0.0118	CcSEcCtD
Zolmitriptan—Urticaria—Metformin—polycystic ovary syndrome	0.00176	0.0115	CcSEcCtD
Zolmitriptan—Abdominal pain—Metformin—polycystic ovary syndrome	0.00175	0.0114	CcSEcCtD
Zolmitriptan—Asthenia—Metformin—polycystic ovary syndrome	0.00159	0.0103	CcSEcCtD
Zolmitriptan—Pruritus—Metformin—polycystic ovary syndrome	0.00157	0.0102	CcSEcCtD
Zolmitriptan—Diarrhoea—Metformin—polycystic ovary syndrome	0.00152	0.00986	CcSEcCtD
Zolmitriptan—Dizziness—Metformin—polycystic ovary syndrome	0.00147	0.00953	CcSEcCtD
Zolmitriptan—Vomiting—Metformin—polycystic ovary syndrome	0.00141	0.00917	CcSEcCtD
Zolmitriptan—Rash—Metformin—polycystic ovary syndrome	0.0014	0.00909	CcSEcCtD
Zolmitriptan—Dermatitis—Metformin—polycystic ovary syndrome	0.0014	0.00908	CcSEcCtD
Zolmitriptan—Headache—Metformin—polycystic ovary syndrome	0.00139	0.00903	CcSEcCtD
Zolmitriptan—Nausea—Metformin—polycystic ovary syndrome	0.00132	0.00856	CcSEcCtD
Zolmitriptan—HTR1D—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000299	0.000364	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000298	0.000363	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000297	0.000363	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000296	0.000362	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PGR—polycystic ovary syndrome	0.000295	0.000359	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000292	0.000357	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000292	0.000357	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000291	0.000355	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00029	0.000354	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000287	0.00035	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000282	0.000344	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000281	0.000343	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000279	0.00034	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—LHB—polycystic ovary syndrome	0.000278	0.00034	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000275	0.000335	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000274	0.000335	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000274	0.000334	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000274	0.000334	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000273	0.000333	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—HSD3B2—polycystic ovary syndrome	0.000272	0.000332	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FST—polycystic ovary syndrome	0.000272	0.000332	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000271	0.000331	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00027	0.00033	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000268	0.000328	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000267	0.000326	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FST—polycystic ovary syndrome	0.000266	0.000325	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LHB—polycystic ovary syndrome	0.000265	0.000324	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000265	0.000323	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000264	0.000322	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000263	0.000322	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000263	0.000321	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000261	0.000319	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000261	0.000318	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LHB—polycystic ovary syndrome	0.00026	0.000317	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000259	0.000316	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000255	0.000311	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000254	0.00031	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000254	0.000309	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000253	0.000308	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000251	0.000306	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000251	0.000306	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00025	0.000305	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SCT—polycystic ovary syndrome	0.000249	0.000303	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000246	0.0003	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000245	0.000299	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000245	0.000299	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000243	0.000297	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000243	0.000297	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—SULT2A1—polycystic ovary syndrome	0.000242	0.000296	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000242	0.000295	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000241	0.000294	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00024	0.000293	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00024	0.000292	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PRL—polycystic ovary syndrome	0.000239	0.000292	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000237	0.000289	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—RRM2—polycystic ovary syndrome	0.000235	0.000287	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000233	0.000284	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000232	0.000283	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000231	0.000282	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000231	0.000281	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00023	0.000281	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000228	0.000278	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000228	0.000278	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000227	0.000278	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000227	0.000277	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—YAP1—polycystic ovary syndrome	0.000226	0.000276	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000226	0.000276	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000225	0.000275	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000223	0.000272	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000223	0.000272	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000222	0.000271	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000221	0.00027	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000221	0.00027	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000221	0.00027	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000218	0.000266	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NAMPT—polycystic ovary syndrome	0.000217	0.000265	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000216	0.000263	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP11A1—polycystic ovary syndrome	0.000215	0.000262	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000214	0.000261	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000213	0.00026	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000211	0.000258	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GNAS—polycystic ovary syndrome	0.00021	0.000257	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000208	0.000254	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000208	0.000254	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000205	0.000251	CbGpPWpGaD
Zolmitriptan—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000205	0.00025	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—INSR—polycystic ovary syndrome	0.000203	0.000248	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000203	0.000248	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FST—polycystic ovary syndrome	0.000203	0.000247	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000202	0.000246	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000201	0.000245	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.0002	0.000244	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.0002	0.000244	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP17A1—polycystic ovary syndrome	0.0002	0.000244	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000199	0.000243	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000198	0.000241	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000197	0.00024	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000193	0.000236	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000193	0.000236	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00019	0.000232	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000189	0.000231	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PGR—polycystic ovary syndrome	0.000188	0.00023	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000187	0.000229	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000187	0.000229	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000187	0.000228	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000186	0.000227	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000185	0.000226	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000184	0.000225	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000183	0.000223	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000178	0.000217	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000177	0.000216	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000175	0.000214	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000175	0.000214	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000175	0.000213	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000175	0.000213	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000174	0.000212	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—TH—polycystic ovary syndrome	0.000173	0.000211	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000172	0.00021	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000171	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000171	0.000209	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00017	0.000207	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000169	0.000206	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000168	0.000205	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000168	0.000205	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000168	0.000205	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000167	0.000204	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000165	0.000202	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000165	0.000202	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—LEP—polycystic ovary syndrome	0.000165	0.000201	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000164	0.0002	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000163	0.000199	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000162	0.000198	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000161	0.000196	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.00016	0.000195	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000159	0.000194	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000159	0.000194	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000158	0.000193	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000154	0.000188	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000153	0.000187	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PRL—polycystic ovary syndrome	0.000153	0.000186	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000152	0.000185	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000151	0.000184	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00015	0.000183	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PRL—polycystic ovary syndrome	0.00015	0.000183	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000147	0.00018	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000147	0.000179	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000146	0.000179	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000145	0.000177	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000144	0.000176	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000144	0.000176	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000142	0.000173	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000142	0.000173	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—POMC—polycystic ovary syndrome	0.000142	0.000173	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GNAS—polycystic ovary syndrome	0.000141	0.000172	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—INS—polycystic ovary syndrome	0.000141	0.000172	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000141	0.000171	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000139	0.000169	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000136	0.000166	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000136	0.000166	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000134	0.000164	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NCOR1—polycystic ovary syndrome	0.000134	0.000164	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.000132	0.000162	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000132	0.000161	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000131	0.00016	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000131	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000131	0.000159	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000129	0.000158	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000128	0.000156	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CYP1A1—polycystic ovary syndrome	0.000127	0.000155	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000126	0.000154	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000126	0.000153	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000125	0.000153	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000125	0.000152	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000123	0.00015	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000122	0.000148	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000121	0.000148	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—MTHFR—polycystic ovary syndrome	0.000119	0.000145	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000118	0.000144	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000115	0.00014	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000114	0.000139	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000114	0.000139	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000113	0.000137	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000111	0.000136	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00011	0.000134	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000108	0.000132	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000108	0.000131	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000105	0.000129	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000105	0.000129	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LEP—polycystic ovary syndrome	0.000105	0.000129	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000104	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LEP—polycystic ovary syndrome	0.000103	0.000126	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.000103	0.000125	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	0.0001	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.0001	0.000122	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	9.72e-05	0.000119	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARG—polycystic ovary syndrome	9.63e-05	0.000118	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.55e-05	0.000117	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—POMC—polycystic ovary syndrome	9.5e-05	0.000116	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—INS—polycystic ovary syndrome	9.44e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IRS1—polycystic ovary syndrome	9.4e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NRG1—polycystic ovary syndrome	9.37e-05	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IRS1—polycystic ovary syndrome	9.2e-05	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—POMC—polycystic ovary syndrome	9.05e-05	0.00011	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—INS—polycystic ovary syndrome	9e-05	0.00011	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	8.94e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.89e-05	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—POMC—polycystic ovary syndrome	8.86e-05	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—INS—polycystic ovary syndrome	8.81e-05	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1—polycystic ovary syndrome	8.71e-05	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT2—polycystic ovary syndrome	8.7e-05	0.000106	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	8.66e-05	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1—polycystic ovary syndrome	8.52e-05	0.000104	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT2—polycystic ovary syndrome	8.52e-05	0.000104	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	8.35e-05	0.000102	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.27e-05	0.000101	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	8.09e-05	9.88e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IRS2—polycystic ovary syndrome	8.03e-05	9.8e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	8.02e-05	9.79e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.97e-05	9.73e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	7.92e-05	9.67e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.86e-05	9.6e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LEP—polycystic ovary syndrome	7.86e-05	9.59e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	7.48e-05	9.13e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	7.36e-05	8.99e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IRS1—polycystic ovary syndrome	7.01e-05	8.56e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—POMC—polycystic ovary syndrome	6.75e-05	8.24e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—INS—polycystic ovary syndrome	6.71e-05	8.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—polycystic ovary syndrome	6.66e-05	8.12e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—polycystic ovary syndrome	6.52e-05	7.96e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1—polycystic ovary syndrome	6.49e-05	7.92e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT2—polycystic ovary syndrome	6.49e-05	7.92e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—TH—polycystic ovary syndrome	6.37e-05	7.78e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	6.2e-05	7.57e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.17e-05	7.53e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—polycystic ovary syndrome	6.15e-05	7.51e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	5.83e-05	7.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.69e-05	6.94e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.57e-05	6.79e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	5.2e-05	6.35e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.97e-05	6.06e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.96e-05	6.05e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.7e-05	5.73e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	4.38e-05	5.35e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.24e-05	5.18e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—polycystic ovary syndrome	3.93e-05	4.8e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—polycystic ovary syndrome	3.85e-05	4.7e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	3.55e-05	4.33e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	3.5e-05	4.27e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—INS—polycystic ovary syndrome	3.48e-05	4.25e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—polycystic ovary syndrome	2.93e-05	3.58e-05	CbGpPWpGaD
